These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8025302)

  • 1. Sulphur amino acid pattern in chronic liver disease.
    Almasio P; Bianchi G; Marchesini G; Luca A; Bugianesi E; Le Grazie C; Pagliaro L
    Ital J Gastroenterol; 1994; 26(1):21-5. PubMed ID: 8025302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis.
    Bianchi G; Brizi M; Rossi B; Ronchi M; Grossi G; Marchesini G
    Metabolism; 2000 Nov; 49(11):1434-9. PubMed ID: 11092507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of fasting serum bile acid in the long-term observation of chronic liver disease.
    Kishimoto Y; Hijiya S; Takeda I
    Am J Gastroenterol; 1985 Feb; 80(2):136-8. PubMed ID: 3970000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
    Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
    Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood amino acids in chronic HBsAg positive liver disease].
    De Marco F; Palmieri G; Capuano G; Gentile R; Nardone G; Parrilli G; Prantera T; Budillon G
    Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1576-81. PubMed ID: 6661322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-diagnostic significance of the determination of bile acids in chronic liver diseases].
    Andreuzzi B; Vai C; Santese R; Andreuzzi P; Cantoni L
    Minerva Med; 1984 Mar; 75(13):749-56. PubMed ID: 6717831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum tumor markers in chronic liver disease.
    Kadayifci A; Simsek H; Savas MC; Toppare M
    Neoplasma; 1996; 43(1):17-21. PubMed ID: 8843954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinolysis as a cause of coagulopathy in patients with chronic diffuse diseases of the liver].
    Serov NA; Sukhanov VA; Podymova SD
    Klin Med (Mosk); 1991 Apr; 69(4):73-5. PubMed ID: 1865658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the "Multitest-CMI" in the evaluation of cutaneous delayed hypersensitivity reaction to antigens in patients with chronic diseases of the liver].
    Juszczyk J; Barałkiewicz G; Bereszyńska I; Adamek J
    Przegl Epidemiol; 1990; 44(4):285-92. PubMed ID: 2100810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.
    Marmo R; Romano M; de Sio I; Peduto A; Caporaso N; Persico M; Coltorti M
    Ital J Gastroenterol; 1993 Jan; 25(1):1-8. PubMed ID: 8428017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma taurine and cysteine levels following an oral methionine load: relationship with coronary heart disease.
    Obeid OA; Johnston K; Emery PW
    Eur J Clin Nutr; 2004 Jan; 58(1):105-9. PubMed ID: 14679374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical improvement in patients with decompensated liver disease caused by hepatitis B after treatment with lamivudine.
    Sponseller CA; Bacon BR; Di Bisceglie AM
    Liver Transpl; 2000 Nov; 6(6):715-20. PubMed ID: 11084057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bile acid metabolism in patients with chronic hepatitis and liver cirrhosis].
    Klemashev IS; Dorofeev AA
    Sov Med; 1984; (6):44-6. PubMed ID: 6463746
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on citrate metabolism in liver injuries. 1. Fasting blood citrate level in chronic hepatitis and liver cirrhosis.
    Kaneshige J
    Acta Med Okayama; 1975 Feb; 29(1):1-8. PubMed ID: 125999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma cysteine, cystine, and glutathione in cirrhosis.
    Chawla RK; Lewis FW; Kutner MH; Bate DM; Roy RG; Rudman D
    Gastroenterology; 1984 Oct; 87(4):770-6. PubMed ID: 6468868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reevaluation of the typing criteria for patients with chronic severe hepatitis].
    Zeng Z; Han YK; Geng H; Chen JM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):53-5. PubMed ID: 16816864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.